6 completed, 2 terminated, 1 unknown. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Completed 6, Terminated 2, Unknown 1 |
Follow hylan: new trials by email Literature Review of hylan trials Research Report on hylan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial Comparing Three Single Dose Injections for Knee Osteoarthritis Zilretta, Synvisc-One 48 MG in 6 ML Prefilled Syringe, Monovisc 88 MG Per 4 ML Prefilled Syringe - Osteoarthritis, Knee | Phase 4 | Terminated | Ohio State University | 6 | 2022-08-02 | 2026-09-17 |
| Knee Injection RCT Ketorolac Tromethamine Injection, Methylprednisolone Acetate Injection, Hylan G-F 20 - Osteoarthritis | Phase 4 | Terminated | UConn Health | 18 | 2018-07-05 | 2020-02-18 |
| Comparison of Single Intra-articular Injection of Hyruan-One With Hylan G-F 20 in Knee Osteoarthritis Hyruan-One, Hylan G-F 20, Normal saline - Knee Osteoarthritis | Phase 4 | Completed | Thammasat University | 276 | 2018-04-01 | 2025-09-22 |
| Outcomes of Injections in Patients Waiting for Total Knee Replacement Hylan G-F 20, Triamcinolone - Osteoarthritis of the Knee | Phase 4 | Unknown | Universidade Federal Fluminense | 120 | 2015-09-01 | 2017-03-27 |
| A Study of the Efficacy and Safety of Synvisc® in Chinese Subjects With Symptomatic Osteoarthritis of the Knee(s) Hylan G-F 20 - Osteoarthritis | Phase 4 | Completed | Sanofi | 237 | 2012-03-01 | 2016-02-24 |
| Evaluation of the Effect of Adding Corticosteroid to Viscosupplementation Hylan GF-20 alone, Triamcinolone - Osteoarthritis | Phase 4 | Completed | University of Sao Paulo General Hospital | 108 | 2011-03-01 | 2014-12-23 |
| Intra-articular Corticosteroid Injection Compared With Single-Shot Hyaluronic Acid for Treatment of Osteoarthritis Knee Hylan G-F 20, Corticosteroid - Knee Osteoarthritis | Phase 4 | Completed | Thammasat University | 100 | 2011-01-01 | 2014-04-22 |
| Study of Safety and Efficacy of 6 mL Synvisc-One (Hylan G-F 20) in Indian Patients With Symptomatic Osteoarthritis of Knee(s) After Initial and Repeat Treatment Synvisc-One - Osteoarthritis | Phase 4 | Completed | Genzyme, a Sanofi Company | 394 | 2010-02-01 | 2017-08-07 |
| Effectiveness and Safety of Synvisc® Versus Usual Treatments in Patients With Knee Osteoarthritis Hylan G-F 20, Standard treatment, Physiotherapy - Osteoarthritis | Phase 4 | Completed | Boehringer Ingelheim | 518 | 1998-10-01 | 2014-07-22 |
Osteoarthritis (6) · Osteoarthritis, Knee (4)
Thammasat University (2) · Boehringer Ingelheim (1) · Genzyme, a Sanofi Company (1) · Ohio State University (1) · Sanofi (1) · UConn Health (1) · Universidade Federal Fluminense (1) · University of Sao Paulo General Hospital (1)
Brazil (2) · Thailand (2) · United States (2) · China (1)
Andre Campos (1) · Michael Baria (1) · Mohamad J. Halawi, MD (1) · Nattapol Tammachote, MD (1) · Nattapol Tammachote, MD, MSc (1) · Olavo Pires de Camargo, Prof. Dr. (1)